Originally posted by cdinz
View Post
The difference comes in the analysis part.
You will have to take into consideration the Intron-Exon Junctions. As a Intron will be taken as a CNV. Also another problem is that if a CNV breakpiomt lies in the Intron, you can not come to know about it.
We have tumor Exome data, done by the True-Seq protocol, hence while doing the analysis use the co-ordinates provided by them.
Comment